Terms: = Gastric cancer AND CCND3, P30281, 896, ENSG00000112576 AND Treatment
17 results:
1. An international Delphi consensus for surgical quality assessment of lymphadenectomy and anastomosis in minimally invasive total gastrectomy for gastric cancer.
Cizmic A; Romic I; Balla A; Barabino N; Anania G; Baiocchi GL; Bakula B; Balagué C; Berlth F; Bintintan V; Bracale U; Egberts JH; Fuchs HF; Gisbertz SS; Gockel I; Grimminger P; van Hillegersberg R; Inaki N; Immanuel A; Korr D; Lingohr P; Mascagni P; Melling N; Milone M; Mintz Y; Morales-Conde S; Moulla Y; Müller-Stich BP; Nakajima K; Nilsson M; Reeh M; Sileri P; Targarona EM; Ushimaru Y; Kim YW; Markar S; Nickel F; Mitra AT
Surg Endosc; 2024 Feb; 38(2):488-498. PubMed ID: 38148401
[TBL] [Abstract] [Full Text] [Related]
2. Incidence and risk factors for venous thromboembolism in the cancer-VTE Registry stomach cancer subcohort.
Yoshikawa T; Sano T; Terashima M; Yamaguchi K; Bando E; Kawabata R; Yabusaki H; Shinohara H; Oba MS; Kimura T; Takita A; Sasako M
Gastric Cancer; 2023 Jul; 26(4):493-503. PubMed ID: 37004667
[TBL] [Abstract] [Full Text] [Related]
3. gastric Linitis Plastica: Clinical Characteristics and Outcomes from the National cancer Database.
Ayub A; Naeem B; Perez A; Tyler D; Klimberg VS
Anticancer Res; 2023 Apr; 43(4):1543-1548. PubMed ID: 36974782
[TBL] [Abstract] [Full Text] [Related]
4. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in gastric cancer.
Song J; Wei R; Huo S; Gao J; Liu X
Front Immunol; 2022; 13():920512. PubMed ID: 35769483
[TBL] [Abstract] [Full Text] [Related]
5. Plasma thioredoxin reductase: a potential diagnostic biomarker for gastric cancer.
Zhu Y; Hu Y; Zhu X; Zhang J; Yuwen D; Wei X; Tang C; Zhang W
Carcinogenesis; 2022 Sep; 43(8):736-745. PubMed ID: 35709525
[TBL] [Abstract] [Full Text] [Related]
6. Determining oncogenic patterns and cancer predisposition through the transcriptomic profile in Mitchell-Riley syndrome with heterotopic gastric mucosa and duodenal atresia: a case report.
Calcaterra V; Chiricosta L; Mazzon E; Gugnandolo A; Alberti D; Maestri L; Meroni M; Vestri E; Verduci E; Dilillo D; Zuccotti G; Pelizzo G
Orphanet J Rare Dis; 2021 Oct; 16(1):455. PubMed ID: 34715892
[TBL] [Abstract] [Full Text] [Related]
7. Prediction of Chemosensitivity in Multiple Primary cancer Patients Using Machine Learning.
Zhang X; Jang MI; Zheng Z; Gao A; Lin Z; Kim KY
Anticancer Res; 2021 May; 41(5):2419-2429. PubMed ID: 33952467
[TBL] [Abstract] [Full Text] [Related]
8. The Discordance of Clinical and Pathologic Staging in Locally Advanced gastric Adenocarcinoma.
Papageorge MV; de Geus SWL; Zheng J; Woods AP; Ng SC; Cassidy MR; McAneny D; Tseng JF; Sachs TE
J Gastrointest Surg; 2021 Jun; 25(6):1363-1369. PubMed ID: 33846934
[TBL] [Abstract] [Full Text] [Related]
9. Clinical Outcomes of Proximal Gastrectomy versus Total Gastrectomy for Proximal gastric cancer: A Systematic Review and Meta-Analysis.
Zhao L; Ling R; Chen J; Shi A; Chai C; Ma F; Zhao D; Chen Y
Dig Surg; 2021; 38(1):1-13. PubMed ID: 33152740
[TBL] [Abstract] [Full Text] [Related]
10. Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.
Nicoară-Farcău O; Han G; Rudler M; Angrisani D; Monescillo A; Torres F; Casanovas G; Bosch J; Lv Y; Thabut D; Fan D; Hernández-Gea V; García-Pagán JC;
Gastroenterology; 2021 Jan; 160(1):193-205.e10. PubMed ID: 32980344
[TBL] [Abstract] [Full Text] [Related]
11. Complications and outcomes in diffuse large B-cell lymphoma with gastric lesions treated with R-CHOP.
Kadota T; Seo S; Fuse H; Ishii G; Itoh K; Yano T; Kaneko K; Tsukasaki K
Cancer Med; 2019 Mar; 8(3):982-989. PubMed ID: 30730104
[TBL] [Abstract] [Full Text] [Related]
12. Randomized Phase II Trial Comparing Site-Specific treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With cancer of Unknown Primary Site.
Hayashi H; Kurata T; Takiguchi Y; Arai M; Takeda K; Akiyoshi K; Matsumoto K; Onoe T; Mukai H; Matsubara N; Minami H; Toyoda M; Onozawa Y; Ono A; Fujita Y; Sakai K; Koh Y; Takeuchi A; Ohashi Y; Nishio K; Nakagawa K
J Clin Oncol; 2019 Mar; 37(7):570-579. PubMed ID: 30653423
[TBL] [Abstract] [Full Text] [Related]
13. Changing patterns of Serum CEA and CA199 for Evaluating the Response to First-line Chemotherapy in Patients with Advanced gastric Adenocarcinoma.
He B; Zhang HQ; Xiong SP; Lu S; Wan YY; Song RF
Asian Pac J Cancer Prev; 2015; 16(8):3111-6. PubMed ID: 25921105
[TBL] [Abstract] [Full Text] [Related]
14. Genetic polymorphisms of CYP2C19 and IL1B have no influence on esomeprazole treatment for mild erosive esophagitis.
Hsu WH; Kuo FC; Hu HM; Hsu PI; Wu DC; Kuo CH
Kaohsiung J Med Sci; 2015 May; 31(5):255-9. PubMed ID: 25910560
[TBL] [Abstract] [Full Text] [Related]
15. Efficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancer.
Wu Y; Wei ZW; He YL; Schwarz RE; Smith DD; Xia GK; Zhang CH
World J Gastroenterol; 2013 Jun; 19(21):3309-15. PubMed ID: 23745033
[TBL] [Abstract] [Full Text] [Related]
16. Perioperative DCF chemotherapy protocol for patients with gastroesophageal adenocarcinoma: correlation between response to treatment and outcome.
Alcindor T; Ferri LE; Marcus V; Andalib A; Hickeson M; Artho G; Chasen M; Thirlwell MP; Ades S
Med Oncol; 2013 Mar; 30(1):377. PubMed ID: 23275118
[TBL] [Abstract] [Full Text] [Related]
17. [The results of treating stomach cancer at a medical center].
Malinovskiĭ NN; Denisov LE; Nikolaev AP; Savchuk BD; Vinogradova NN; Luk'ianov VM; Ushakova TI
Khirurgiia (Mosk); 1998; (6):68-71. PubMed ID: 9680808
[TBL] [Abstract] [Full Text] [Related]
